Delivery Order SPE2DB22D3501-SPE2DB25FWR69
- Not listed
- The Defense Logistics Agency awarded a $10,360.75 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units) with a ceiling value of $9,867.80 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units) with a contract ceiling value of $4,110.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fingolimod 0.5 mg capsules (30-count units) with a ceiling value of $1,497.86. This competitive, non-set-aside award was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizing firm fixed-price pricing. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $22,005.93 to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fingolimod is a disease-modifying therapy used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $17,530.56 to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 4, 2025, just one day after the award date of September 3, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fingolimod 0.5 mg capsules (30-count) with a ceiling value of $60,526.11. This is a firm fixed price, non-competitive delivery order that was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fingolimod is a disease-modifying therapy used in the treatment of multiple...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units) with a ceiling value of $9,393.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count units) under a firm fixed price contract valued at $30,185.00. The contract, awarded June 18, 2025, with completion targeted for June 20, 2025, represents a non-competitive set-aside award utilizing standard competitive procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform all...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has a ceiling value of $3,666.91 and a period of performance through June 14, 2023. The contract is not set-aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWR69Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,634.02 to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count packages) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 7/31/25 |